Latest revenue
$1.60B
as of 2026-03-31
Latest net income
$39.9M
as of 2026-03-31
Net margin
2.5%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.32B
- Enterprise value
- $1.32B
- P/E (trailing)
- 9.7×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $15.48
- 52-wk low
- $8.07
- Beta
- —
- Shares out
- 143.4M
5-year trend
What this company does
Item 1. Business Overview Ardent Health, Inc. was initially formed in Delaware in 2015 as Ardent Health Partners, LLC. On July 17, 2024, Ardent Health Partners, LLC converted from a Delaware limited liability company into a Delaware corporation in connection with its initial public offering and changed its name to Ardent Health Partners, Inc. On June 3, 2025, Ardent Health Partners, Inc. changed its name to Ardent Health, Inc. Ardent Health, Inc. is a holding company that has affiliates that operate acute care hospitals and other healthcare facilities and employ physicians. The terms "Ardent," the "Company," "we," "our" and "us," as used in this Annual Report on Form 10-K ("Annual Report"),…
AI summary unavailable — showing raw filing excerpt
Generated from ARDT's filing dated 2026-03-16
Key risks
Item 1A. Risk Factors Risk Factors Summary An investment in our securities involves numerous risks described in “Risk Factors” below and elsewhere in this Annual Report. Key risks include, but are not limited to, the following: •changes in government healthcare programs, including Medicare and Medicaid, could have an adverse effect on our revenues and business; •reduction in the reimbursement rates paid by commercial payors, increased reimbursement denials or payment delays by commercial payors, our inability to retain and negotiate favorable contracts with private third party payors, or an increasing volume of uninsured or underinsured patients; •effects of changes in laws, regulations,…
AI summary unavailable — showing raw filing excerpt
Generated from ARDT's filing dated 2026-03-16
Profitability
Net margin
2.1%
39.1%Return on equity
10.5%
43.3%Return on assets
2.6%
39.5%Leverage
Debt / equity
3.11×
8.1%Long-term debt / equity
0.84×
13.0%Debt / assets
75.7%
2.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $1.60B | +7.0% | $39.9M | -3.7% | 2.5% |
Q4 2025 2025-12-31 | $1.61B | -0.1% | $45.0M | -60.6% | 2.8% |
Q3 2025 2025-09-30 | $1.58B | +8.8% | $-23.5M | -189.2% | -1.5% |
Q2 2025 2025-06-30 | $1.65B | +11.9% | $73.0M | +70.6% | 4.4% |
Q1 2025 2025-03-31 | $1.50B | +4.0% | $41.4M | +53.0% | 2.8% |
Q4 2024 2024-12-31 | $1.61B | — | $114.2M | — | 7.1% |
Q3 2024 2024-09-30 | $1.45B | +5.2% | $26.3M | +26.3% | 1.8% |
Q2 2024 2024-06-30 | $1.47B | +7.5% | $42.8M | +29.3% | 2.9% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-General Medical & Surgical Hospitals, NEC · SIC 8062
Your notes
Keep private notes on ARDT — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
0
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value |
|---|
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ARDT
Institutional value
$54.3M
Total shares held
6.7M
Distinct holders
67
-59 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1.8M | $15.1M | +52.2K (+3.1%) | Added |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $8.6M | — | New |
| 3 | FIRST TRUST ADVISORS LP | 478.8K | $4.1M | +198.6K (+70.9%) | Added |
| 4 | UBS Group AG | 450.7K | $3.9M | +334.0K (+286.3%) | Added |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 279.6K | $2.4M | — | New |
| 6 | DENALI ADVISORS LLC | 249.4K | $2.1M | +0 (+0.0%) | No change |
| 7 | Bank of New York Mellon Corp | 241.1K | $2.1M | +9.7K (+4.2%) | Added |
| 8 | JANE STREET GROUP, LLC | 194.0K | $1.7M | +129.2K (+199.4%) | Added |
| 9 | JPMORGAN CHASE & CO | 168.6K | $1.4M | -70.1K (-29.4%) | Trimmed |
| 10 | Vanguard Global Advisers, LLC | 161.6K | $1.4M | — | New |
| 11 | VANGUARD FIDUCIARY TRUST CO | 151.8K | $1.3M | — | New |
| 12 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 121.9K | $1.0M | +0 (+0.0%) | No change |
| 13 | WEDGE CAPITAL MANAGEMENT L L P/NC | 104.8K | $897.0K | -7.9K (-7.0%) | Trimmed |
| 14 | Invesco Ltd. | 73.8K | $631.9K | +2.5K (+3.5%) | Added |
| 15 | NEW YORK STATE COMMON RETIREMENT FUND | 71.9K | $615.5K | +0 (+0.0%) | No change |
| 16 | Lido Advisors, LLC | 70.0K | $599.2K | -21.0K (-23.1%) | Trimmed |
| 17 | Nuveen, LLC | 68.3K | $584.6K | +37.6K (+122.6%) | Added |
| 18 | STRS OHIO | 59.6K | $510.2K | -2.8K (-4.5%) | Trimmed |
| 19 | CITIGROUP INC | 58.9K | $504.6K | +2.0K (+3.6%) | Added |
| 20 | Swiss National Bank | 55.5K | $475.1K | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ARDT's latest filing finishes processing.